Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Postdoctoral Research Award (CPRA) program

Direct Payment

$140,000.00

Time-resolved single-cell analysis of innate immune responses to SARS-CoV-2 infection in the upper respiratory tract

EF 2025-26

Résumé
In response to viral infection, the host mounts immune defenses to protect itself and limit the spread of the virus. Our immune system's first line of defense is the interferon system, which is activated when cells first detect the presence of a virus and tell surrounding cells to mount protective defenses. People who activate the interferon response early are more likely to have asymptomatic SARS-CoV-2 infection. Yet, we don't understand why interferon is activated early enough to prevent disease in some people but not in others. Timing of both virus replication and host interferon responses is highly dynamic and variable, likely affecting the balance between control and spread of infection. In this proposal, I will use a novel sequencing technique that can measure the dynamics of virus replication and host interferon responses in human nasal epithelial cells. From this data, I will map the communication pathways between cells to determine how viral replication impacts interferon activation and signaling to alert and help neighboring cells resist infection. These studies will tell us why some patients have early, successful interferon-mediated control of SARS-CoV-2 infection. Given the importance of the interferon response for protection from all viruses, this knowledge can be harnessed to identify and develop novel antiviral strategies for SARS-CoV-2 and other respiratory virus infections.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
537177
Name
Barnard Trisha R
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Time-resolved single-cell analysis of innate immune responses to SARS-CoV-2 infection in the upper respiratory tract
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Cell-Cell Communication; Innate Immunity; Interferon Response; Nasal Epithelial Cells; Sars-Cov-2; Single-Cell Rna Sequencing; Viral Replication
Abstract
In response to viral infection, the host mounts immune defenses to protect itself and limit the spread of the virus. Our immune system's first line of defense is the interferon system, which is activated when cells first detect the presence of a virus and tell surrounding cells to mount protective defenses. People who activate the interferon response early are more likely to have asymptomatic SARS-CoV-2 infection. Yet, we don't understand why interferon is activated early enough to prevent disease in some people but not in others. Timing of both virus replication and host interferon responses is highly dynamic and variable, likely affecting the balance between control and spread of infection. In this proposal, I will use a novel sequencing technique that can measure the dynamics of virus replication and host interferon responses in human nasal epithelial cells. From this data, I will map the communication pathways between cells to determine how viral replication impacts interferon activation and signaling to alert and help neighboring cells resist infection. These studies will tell us why some patients have early, successful interferon-mediated control of SARS-CoV-2 infection. Given the importance of the interferon response for protection from all viruses, this knowledge can be harnessed to identify and develop novel antiviral strategies for SARS-CoV-2 and other respiratory virus infections.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Barnard, Trisha R
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~